Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
0
1
0
0
0
SeqLL Inc.
Share · US81734C3043 · SQL (XNAS)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of SeqLL Inc.
Analyst Grade Summary
No Price
Share Float & Liquidity
Free Float -
Shares Float -
Shares Outstanding 380.648,00
Company Profile for SeqLL Inc. Share
SeqLL Inc. operates as a life sciences instrumentation and research services company worldwide. The company designs, develops, and manufactures genetic analysis technologies. It offers true single molecule sequencing (tSMS) platform, which offers a single molecule solution for DNA and RNA sequencing. The company has a collaboration agreement with Bernstein Laboratory, Ting Laboratory, The Jackson Laboratory for Genomic Medicine, Weizmann Institute of Science, True Bearing Diagnostics, Inc., and Tetracore, Inc. It serves academic and government institutions, hospitals and medical centers, pharmaceutical and biotechnology companies, and non-profit research organizations. The company was founded in 2013 and is based in Billerica, Massachusetts.
Company Data
Name SeqLL Inc.
Company SeqLL Inc.
Symbol SQL
Website
https://seqll.com
Primary Exchange 
NASDAQ
NASDAQ
ISIN US81734C3043
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Daniel Robert Jones
Country United States of America
Currency USD
Employees 0,0 T
Address 3 Federal Street, 01821 Billerica
IPO Date 2021-08-27
Stock Splits
| Date | Split |
|---|---|
| 31.08.2023 | 1:40 |
Ticker Symbols
| Name | Symbol |
|---|---|
| NASDAQ | SQL |
More Shares
Investors who hold SeqLL Inc. also have the following shares in their portfolio:
